These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 6689548)

  • 1. Further purification of a CFU-S inhibitor: in vivo effects after cytosine arabinoside treatment.
    Wdzieczak-Bakala J; Guigon M; Lenfant M; Frindel E
    Biomed Pharmacother; 1983; 37(9-10):467-71. PubMed ID: 6689548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Inhibitors of bone marrow stem cells proliferation. Possible applications during chemotherapy (author's transl)].
    Guigon M; Frindel E
    Bull Cancer; 1981; 68(2):150-3. PubMed ID: 7236900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection of mice against lethal doses of 1 beta-D-arabinofuranosylcytosine by pluripotent stem cell inhibitors.
    Guigon M; Mary JY; Enouf J; Frindel E
    Cancer Res; 1982 Feb; 42(2):638-41. PubMed ID: 7055808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effects of high doses of cytosine arabinoside on pluripotent stem cells (CFU-S).
    Guigon M; Izumi-Hisha H; Mary JY
    Exp Hematol; 1989 Feb; 17(2):203-7. PubMed ID: 2912743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of CFU-S entry into cell cycle after irradiation and drug treatment.
    Guigon M; Frindel E
    Biomedicine; 1978 Jul; 29(5):176-8. PubMed ID: 719133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mice transduced with double-mutant dihydrofolate reductase-cytidine deaminase fusion gene attained protection from high dose chemotherapy].
    Lu P; Lu Y; Pang K; Wang SB; Chen JQ; Xu HM; Wang JK; Zhao SC
    Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):998-1001. PubMed ID: 16194358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On control of the hematopoietic cell proliferation.
    Necas E; Sefc L; Znojil V
    Stem Cells; 1993 Jul; 11(4):319-25. PubMed ID: 8401255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human placental low molecular weight factors inhibit the entry into cell cycle of murine pluripotent stem cells.
    Lopez M; Wdzieczak-Bakala J; Pradelles P; Frindel E
    Leukemia; 1991 Mar; 5(3):270-2. PubMed ID: 2013983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of hematotoxic side effects of cytostatic drugs in mice by a synthetic hemoregulatory peptide.
    Paukovits WR; Guigon M; Binder KA; Hergl A; Laerum OD; Schulte-Hermann R
    Cancer Res; 1990 Jan; 50(2):328-32. PubMed ID: 2295072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activated granulocytes oxidize the endogenous stem cell inhibitory peptide pGlu-Glu-Asp-Cys-Lys (pEEDCK) to the stimulatory dimer: a redox-mediated mechanism for demand-induced hematopoietic regulation.
    Paukovits WR; Paukovits JB; Moser MH; Konstantinov S; Schulte-Hermann R
    Exp Hematol; 1998 Aug; 26(9):851-8. PubMed ID: 9694506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hematopoietic stem cell deficit of transplanted bone marrow previously exposed to cytotoxic agents.
    Neben S; Hellman S; Montgomery M; Ferrara J; Mauch P
    Exp Hematol; 1993 Jan; 21(1):156-62. PubMed ID: 8435103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A convenient source of CFU-s inhibitors: the fetal calf liver.
    Guigon M; Wdzieczak-Bakala J; Mary JY; Lenfant M
    Cell Tissue Kinet; 1984 Jan; 17(1):49-55. PubMed ID: 6692465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of cytokine treatment (granulocyte colony-stimulating factor and stem cell factor) on hematopoiesis and the circulating pool of hematopoietic stem cells in mice.
    Drize N; Chertkov J; Samoilina N; Zander A
    Exp Hematol; 1996 Jun; 24(7):816-22. PubMed ID: 8647232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The effect of cyclophosphamide on the erythropoietic stem cell compartment].
    Milenković P
    Bilt Hematol Transfuz; 1980; 8(1):91-7. PubMed ID: 7337685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of specific interleukin-1 receptor blockade on hematopoietic stem cell proliferation].
    Stosić-Grujicić S; Milenković P; Ivanović Z; Lukić M
    Srp Arh Celok Lek; 1994; 122 Suppl 1():13-4. PubMed ID: 18173175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of endogenous acetyl-ser-asp-lys-pro plasma levels in mice and the kinetics of pluripotent hemopoietic stem cells entry into the cycle after cytosine arabinoside treatment: fundamental and clinical aspects.
    Frindel E; Masse A; Pradelles P; Volkov L; Rigaud M
    Leukemia; 1992 Jun; 6(6):599-601. PubMed ID: 1602798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic manipulation of cytokines: transforming growth factor beta-1 protects mice treated with lethal doses of cytarabine.
    Pierce DF; Coffey RJ
    Am Surg; 1994 Jan; 60(1):18-25. PubMed ID: 8273969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simple, one-step clonal assay allows the sequential detection of committed (CFU-GM-like) progenitors and several subsets of primitive (HPP-CFC) murine progenitors.
    Ivanović Z; Bartolozzi B; Bernabei PA; Cipolleschi MG; Milenkovic P; Praloran V; DelloSbarba P
    Stem Cells; 1999; 17(4):219-25. PubMed ID: 10437985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of stem cell factor (c-kit ligand), granulocyte-macrophage colony stimulating factor and interleukin 3 on hematopoietic progenitors in human long-term bone marrow cultures.
    Lemoli RM; Gulati SC
    Stem Cells; 1993 Sep; 11(5):435-44. PubMed ID: 7694721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.